NAAG sent a letter to the Food and Drug Administration (FDA) in response to their request for comments regarding “Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds.”
Lead States
District of Columbia, Oklahoma
Signatory States
AK, AL, CA, CO, CT, DC, DE, GU, HI, IA, ID, IL, KY, LA, MA, MD, ME, MI, MN, MP, MS, MT, NC, ND, NE, NJ, NM, NY, OH, OK, OR, PA, RI, TN, VA, VT, WA
To provide you more clarity about how we collect, store and use personal information, and your rights to control that information, we have updated our privacy policy, which also explains how we use cookies. You consent to our cookies if you continue to use our website.I Agree
